← Leaderboards
Alan Thevenet N. Tita
University Of Alabama At Birmingham
$31,628,801
Attributed
$51,032,278
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.2M · FY2010–25$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,032,278 · 12
By mechanism
U01$25,489,563 · 3
R01$20,598,992 · 4
UG1$2,656,392 · 1
U10$931,214 · 1
R33$513,284 · 1
K12$491,533 · 1
Top collaborators
- Jeff M Szychowski8 shared
- Henna Budhwani5 shared
- Comfort Chu Enah5 shared
- Bertha Hidalgo5 shared
- Suzanne Oparil5 shared
- Hemant K. Tiwari5 shared
- Paula Catherine Chandler-Laney3 shared
- Rebecca Gersnoviez Clifton3 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Michele Kong$4,039,938
- Hemant K. Tiwari$8,608,716
- Bertha Hidalgo$2,981,184
- Michael J Bertram$7,594,636
- Mona N. Fouad$53,629,242
Others in their field
Top investigators on “Pregnancy”
- Chanza Baytop · Westat, Inc.$271,217,917
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$158,777,707
- Barbara Driver · Westat, Inc.$117,058,181
- Myron S Cohen · Family Health International$101,800,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
Research focus
PregnancyPerinatalSiteDiscipline Of ObstetricsPremature BirthMedicalWomanChronicHypertensionDesignPre-EclampsiaAlabamaUniversitiesPregnant WomenResourcesFetalParticipantFollow-UpFutureNational Institute Of Child Health And Human DevelopmentSafetyAffectRandomizedNewborn Infant
Grant awards (50)
Adjunctive Azithromycin Prophylaxis for Scheduled/Prelabor Cesarean Delivery$3,341,494
U01 · FY2025 · HD
Gestational hypertension and preeclampsia blood pressure (BP) Treatment goals <140/90 vs. <160/110 mmHg: The GOALPOST Trial$2,011,151
U01 · FY2025 · HD
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,007,149
R01 · FY2025 · HL · contact PI
Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child).$1,485,190
R01 · FY2025 · HD · contact PI
Epigenetic biomarkers of preeclampsia risk among mothers with chronic hypertension$546,481
R01 · FY2025 · HL
UAB Interdisciplinary Research Scholars' Program in Women's Health$491,533
K12 · FY2025 · AR
Maternal-Fetal Medicine Units (MFMU) Network$326,700
UG1 · FY2025 · HD · contact PI
Adjunctive Azithromycin Prophylaxis for Scheduled/Prelabor Cesarean Delivery$3,614,140
U01 · FY2024 · HD
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$1,976,808
R01 · FY2024 · HL · contact PI
Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child).$1,584,627
R01 · FY2024 · HD · contact PI
Epigenetic biomarkers of preeclampsia risk among mothers with chronic hypertension$656,920
R01 · FY2024 · HL
Maternal-Fetal Medicine Units (MFMU) Network$326,700
UG1 · FY2024 · HD · contact PI
Medical Information Service via mobile Telephone (m-MIST TM) Provider Support to Improve Pregnancy Outcomes$169,950
R33 · FY2024 · HD · contact PI
Epigenetic biomarkers of preeclampsia risk among mothers with chronic hypertension$73,127
R01 · FY2024 · HL
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,046,886
R01 · FY2023 · HL · contact PI
Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child).$1,639,665
R01 · FY2023 · HD · contact PI
Epigenetic biomarkers of preeclampsia risk among mothers with chronic hypertension$675,787
R01 · FY2023 · HL
Maternal-Fetal Medicine Units (MFMU) Network$326,700
UG1 · FY2023 · HD · contact PI
Medical Information Service via mobile Telephone (m-MIST TM) Provider Support to Improve Pregnancy Outcomes$171,667
R33 · FY2023 · HD · contact PI
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,103,237
R01 · FY2022 · HL · contact PI
Epigenetic biomarkers of preeclampsia risk among mothers with chronic hypertension$642,616
R01 · FY2022 · HL
NICHD Maternal-Fetal Medicine Units Networks$297,000
UG1 · FY2022 · HD · contact PI
Medical Information Service via mobile Telephone (m-MIST TM) Provider Support to Improve Pregnancy Outcomes$171,667
R33 · FY2022 · HD · contact PI
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,352,905
R01 · FY2021 · HL · contact PI
NICHD Maternal-Fetal Medicine Units Networks$262,091
UG1 · FY2021 · HD · contact PI
Medical Information Service via mobile Telephone (m-MIST TM) Provider Support to Improve Pregnancy Outcomes$167,846
R21 · FY2021 · HD · contact PI
Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating Center$3,700,859
U01 · FY2020 · HL · contact PI
NICHD Maternal-Fetal Medicine Units (MFMU) Network$279,300
UG1 · FY2020 · HD · contact PI
Medical Information Service via mobile Telephone (m-MIST TM) Provider Support to Improve Pregnancy Outcomes$183,454
R21 · FY2020 · HD · contact PI
Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating Center$3,754,798
U01 · FY2019 · HL · contact PI
NICHD Maternal-Fetal Medicine Units (MFMU) Network$279,300
UG1 · FY2019 · HD · contact PI
Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating Center$3,814,766
U01 · FY2018 · HL · contact PI
NICHD Maternal-Fetal Medicine Units (MFMU) Network$279,300
UG1 · FY2018 · HD · contact PI
NICHD Maternal-Fetal Medicine Units (MFMU) Network$279,300
UG1 · FY2017 · HD · contact PI
Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating Center$1
U01 · FY2017 · HL · contact PI
NICHD Maternal-Fetal Medicine Units (MFMU) Network$1
UG1 · FY2016 · HD · contact PI
Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating Center$2,804,575
U01 · FY2015 · HL · contact PI
NICHD Materal Fetal Medicine Units Network$1
U10 · FY2015 · HD · contact PI
Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating Center$2,447,779
U01 · FY2014 · HL · contact PI
NICHD Materal Fetal Medicine Units Network$1
U10 · FY2014 · HD · contact PI
Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial$566,453
R01 · FY2013 · HD · contact PI
Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial$434,384
R01 · FY2013 · HD · contact PI
NICHD Materal Fetal Medicine Units Network$1
U10 · FY2013 · HD · contact PI
Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial$592,975
R01 · FY2012 · HD · contact PI
NICHD Materal Fetal Medicine Units Network$288,605
U10 · FY2012 · HD · contact PI
Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial$602,987
R01 · FY2011 · HD · contact PI
NICHD Materal Fetal Medicine Units Network$293,000
U10 · FY2011 · HD · contact PI
NICHD Maternal Fetal Medicine Units Network$83,604
U10 · FY2011 · HD · contact PI
Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial$610,795
R01 · FY2010 · HD · contact PI
NICHD Maternal Fetal Medicine Units Network$266,002
U10 · FY2010 · HD · contact PI